Next Article in Journal
Secukinumab Loss of Efficacy Is Perfectly Counteracted by the Introduction of Combination Therapy (Rescue Therapy): Data from a Multicenter Real-Life Study in a Cohort of Italian Psoriatic Patients That Avoided Secukinumab Switching
Next Article in Special Issue
Comparative Evaluation of Radiochemical and Biological Properties of 131I- and [99mTc]Tc(CO)3-Labeled RGD Analogues Planned to Interact with the αvβ3 Integrin Expressed in Glioblastoma
Previous Article in Journal
How Molecular Topology Can Help in Amyotrophic Lateral Sclerosis (ALS) Drug Development: A Revolutionary Paradigm for a Merciless Disease
Previous Article in Special Issue
Sweetening Pharmaceutical Radiochemistry by 18F-Fluoroglycosylation: Recent Progress and Future Prospects
 
 
Article

Article Versions Notes

Pharmaceuticals 2022, 15(1), 96; https://doi.org/10.3390/ph15010096
Action Date Notes Link
article xml file uploaded 14 January 2022 12:37 CET Original file -
article xml uploaded. 14 January 2022 12:37 CET Update -
article pdf uploaded. 14 January 2022 12:37 CET Version of Record https://www.mdpi.com/1424-8247/15/1/96/pdf-vor
article html file updated 14 January 2022 12:38 CET Original file -
article xml file uploaded 15 January 2022 01:17 CET Update -
article xml uploaded. 15 January 2022 01:17 CET Update https://www.mdpi.com/1424-8247/15/1/96/xml
article pdf uploaded. 15 January 2022 01:17 CET Updated version of record https://www.mdpi.com/1424-8247/15/1/96/pdf
article html file updated 15 January 2022 01:18 CET Update -
article html file updated 15 January 2022 01:19 CET Update -
article html file updated 15 January 2022 01:19 CET Update -
article html file updated 15 January 2022 01:19 CET Update -
article html file updated 31 July 2022 03:50 CEST Update https://www.mdpi.com/1424-8247/15/1/96/html
Back to TopTop